cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
STAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-21.1	3.49e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-21.1	3.49e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-21.09	4.1e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-21.09	4.1e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-21.09	4.1e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-21.09	4.1e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-21.05	5.55e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-21.05	5.55e-66	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-20.99	1.02e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-20.99	1.02e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-20.96	1.41e-65	-0.82	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-20.96	1.41e-65	-0.82	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-20.95	1.53e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-20.95	1.53e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	20.91	2.38e-65	0.84	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	20.91	2.38e-65	0.84	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-20.89	2.72e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-20.89	2.72e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-20.86	3.9e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-20.86	3.9e-65	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	20.76	9.76e-65	0.84	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	20.76	9.76e-65	0.84	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-20.64	3.1e-64	-0.83	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-20.64	3.1e-64	-0.83	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-20.41	3.16e-63	-0.84	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-20.41	3.16e-63	-0.84	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-19.7	3.22e-60	-0.81	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-19.7	3.22e-60	-0.81	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-19.65	5.32e-60	-0.81	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-19.65	5.32e-60	-0.81	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-18.73	4.41e-56	-0.83	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-18.73	4.41e-56	-0.83	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-14.83	1.14e-39	-0.76	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-14.83	1.14e-39	-0.76	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
STAD	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	9.21	2.18e-18	0.53	0.43	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	9.18	2.72e-18	0.53	0.42	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	9.14	3.55e-18	0.53	0.42	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	9.1	4.85e-18	0.52	0.42	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	9.08	5.62e-18	0.52	0.42	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	9.06	6.62e-18	0.52	0.42	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs10932796	MIMAT0014996	hsa-miR-3131	9.06	6.7e-18	0.49	0.42	Height;	chr2:219156790	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.627	rs2293070	MIMAT0014996	hsa-miR-3131	9.05	7.3e-18	0.48	0.42	Height;	chr2:219158882	chr2:219058725~219058747:-
STAD	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	9.03	8.69e-18	0.52	0.42	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	9.03	8.69e-18	0.52	0.42	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	9.02	9.12e-18	0.51	0.42	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	8.99	1.11e-17	0.51	0.42	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs12694452	MIMAT0014996	hsa-miR-3131	-8.96	1.41e-17	-0.48	-0.42	Height;	chr2:219162677	chr2:219058725~219058747:-
STAD	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	8.88	2.56e-17	0.51	0.41	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.745	rs7572601	MIMAT0014996	hsa-miR-3131	8.88	2.57e-17	0.48	0.41	Height;	chr2:219154762	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs10171368	MIMAT0014996	hsa-miR-3131	8.87	2.88e-17	0.5	0.41	Height;	chr2:219069055	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.784	rs7578383	MIMAT0014996	hsa-miR-3131	8.84	3.39e-17	0.5	0.41	Height;	chr2:219066129	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.784	rs6730783	MIMAT0014996	hsa-miR-3131	8.83	3.67e-17	0.5	0.41	Height;	chr2:219058113	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs897477	MIMAT0014996	hsa-miR-3131	8.81	4.23e-17	0.49	0.41	Height;	chr2:219076341	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs6711613	MIMAT0014996	hsa-miR-3131	8.79	4.95e-17	0.49	0.41	Height;	chr2:219082969	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.784	rs11690649	MIMAT0014996	hsa-miR-3131	8.79	4.95e-17	0.49	0.41	Height;	chr2:219083049	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs10164493	MIMAT0014996	hsa-miR-3131	8.79	4.95e-17	0.49	0.41	Height;	chr2:219083370	chr2:219058725~219058747:-
STAD	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	8.78	5.33e-17	0.52	0.41	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs6436114	MIMAT0014996	hsa-miR-3131	8.77	5.73e-17	0.48	0.41	Height;	chr2:219138112	chr2:219058725~219058747:-
STAD	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	8.77	5.85e-17	0.51	0.41	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	8.77	5.85e-17	0.51	0.41	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	8.76	6.22e-17	0.52	0.41	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs1869802	MIMAT0014996	hsa-miR-3131	8.76	6.54e-17	0.49	0.41	Height;	chr2:219112311	chr2:219058725~219058747:-
STAD	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	8.7	9.55e-17	0.51	0.41	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	8.69	1.03e-16	0.51	0.41	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	8.67	1.2e-16	0.51	0.4	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	8.66	1.28e-16	0.5	0.4	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.784	rs10168527	MIMAT0014996	hsa-miR-3131	8.65	1.39e-16	0.49	0.4	Height;	chr2:219107653	chr2:219058725~219058747:-
STAD	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	8.62	1.72e-16	0.5	0.4	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs9784128	MIMAT0014996	hsa-miR-3131	-8.61	1.93e-16	-0.49	-0.4	Height;	chr2:219113916	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.871	rs6436109	MIMAT0014996	hsa-miR-3131	8.58	2.42e-16	0.49	0.4	Height;	chr2:219115759	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs6732562	MIMAT0014996	hsa-miR-3131	8.57	2.5e-16	0.48	0.4	Height;	chr2:219102140	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.826	rs7599778	MIMAT0014996	hsa-miR-3131	8.57	2.54e-16	0.48	0.4	Height;	chr2:219096938	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.871	rs6724718	MIMAT0014996	hsa-miR-3131	-8.56	2.78e-16	-0.46	-0.4	Height;	chr2:219139521	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.784	rs1378642	MIMAT0014996	hsa-miR-3131	8.39	9.46e-16	0.48	0.39	Height;	chr2:219085388	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.871	rs6436113	MIMAT0014996	hsa-miR-3131	8.36	1.16e-15	0.47	0.39	Height;	chr2:219120176	chr2:219058725~219058747:-
STAD	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	8.36	1.17e-15	0.49	0.39	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
STAD	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	8.36	1.19e-15	0.48	0.39	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	8.35	1.27e-15	0.49	0.39	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	8.29	1.89e-15	0.49	0.39	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
STAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-8.28	2.11e-15	-0.59	-0.39	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-8.28	2.11e-15	-0.59	-0.39	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
STAD	cis	rs6753739	0.871	rs2030450	MIMAT0014996	hsa-miR-3131	8.26	2.35e-15	0.46	0.39	Height;	chr2:219132157	chr2:219058725~219058747:-
STAD	cis	rs6753739	0.871	rs6436110	MIMAT0014996	hsa-miR-3131	8.22	3.14e-15	0.47	0.39	Height;	chr2:219116231	chr2:219058725~219058747:-
STAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-8.18	4.3e-15	-0.58	-0.39	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-8.18	4.3e-15	-0.58	-0.39	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
STAD	cis	rs6753739	0.784	rs437512	MIMAT0014996	hsa-miR-3131	8.11	6.77e-15	0.47	0.38	Height;	chr2:219061446	chr2:219058725~219058747:-
STAD	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-7.97	1.78e-14	-0.43	-0.38	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-7.92	2.53e-14	-0.42	-0.37	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	7.91	2.83e-14	0.41	0.37	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	7.89	3.18e-14	0.54	0.37	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	7.87	3.69e-14	0.53	0.37	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
STAD	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	7.87	3.7e-14	0.68	0.37	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
STAD	cis	rs6753739	0.871	rs10174319	MIMAT0014996	hsa-miR-3131	-7.81	5.43e-14	-0.45	-0.37	Height;	chr2:219140586	chr2:219058725~219058747:-
STAD	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	7.75	8.49e-14	0.52	0.37	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.871	rs4674360	MIMAT0014996	hsa-miR-3131	-7.74	8.73e-14	-0.44	-0.37	Height;	chr2:219144943	chr2:219058725~219058747:-
STAD	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	7.67	1.44e-13	0.52	0.36	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-7.58	2.68e-13	-0.41	-0.36	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-7.51	4.29e-13	-0.47	-0.36	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
STAD	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-7.49	4.89e-13	-0.46	-0.36	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
STAD	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-7.48	5.05e-13	-0.4	-0.36	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-7.41	8.28e-13	-0.47	-0.35	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
STAD	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	7.38	1.01e-12	0.42	0.35	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	7.38	1.01e-12	0.42	0.35	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	7.29	1.78e-12	0.42	0.35	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
STAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-7.28	1.9e-12	-0.53	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-7.28	1.9e-12	-0.53	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
STAD	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-7.25	2.28e-12	-0.24	-0.35	Migraine;	chr10:103394332	chr10:103394341~103394361:-
STAD	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	7.25	2.28e-12	0.42	0.35	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	7.2	3.26e-12	0.44	0.34	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
STAD	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-7.19	3.41e-12	-0.4	-0.34	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-7.18	3.63e-12	-0.21	-0.34	Migraine;	chr10:103415374	chr10:103394301~103394322:-
STAD	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	7.17	3.95e-12	0.41	0.34	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	7.17	3.95e-12	0.41	0.34	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	7.14	4.82e-12	0.41	0.34	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-7.13	5.13e-12	-0.23	-0.34	Migraine;	chr10:103369141	chr10:103394341~103394361:-
STAD	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-7.09	6.33e-12	-0.6	-0.34	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
STAD	cis	rs6011674	1	rs11908424	MIMAT0016888	hsa-miR-4326	-7.09	6.51e-12	-0.69	-0.34	Response to cytadine analogues (cytosine arabinoside);	chr20:63232603	chr20:63286818~63286837:+
STAD	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-7.07	7.26e-12	-0.41	-0.34	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-7.07	7.26e-12	-0.41	-0.34	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-7.06	7.74e-12	-0.21	-0.34	Migraine;	chr10:103369141	chr10:103394301~103394322:-
STAD	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	7.05	8.27e-12	0.41	0.34	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	7.05	8.27e-12	0.41	0.34	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	7.04	8.85e-12	0.4	0.34	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	7.04	8.85e-12	0.4	0.34	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	7.04	8.98e-12	0.41	0.34	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	7.04	9.15e-12	0.4	0.34	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	7.04	9.15e-12	0.4	0.34	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	7.04	9.17e-12	0.4	0.34	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	7.04	9.17e-12	0.4	0.34	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	7.04	9.17e-12	0.4	0.34	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-7.03	9.22e-12	-0.43	-0.34	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-7.03	9.34e-12	-0.23	-0.34	Migraine;	chr10:103365694	chr10:103394341~103394361:-
STAD	cis	rs6011674	1	rs59784306	MIMAT0016888	hsa-miR-4326	-7.03	9.56e-12	-0.69	-0.34	Response to cytadine analogues (cytosine arabinoside);	chr20:63228244	chr20:63286818~63286837:+
STAD	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-7.03	9.62e-12	-0.23	-0.34	Migraine;	chr10:103415374	chr10:103394341~103394361:-
STAD	cis	rs6011674	1	rs1555337	MIMAT0016888	hsa-miR-4326	7.02	1.03e-11	0.69	0.34	Response to cytadine analogues (cytosine arabinoside);	chr20:63232289	chr20:63286818~63286837:+
STAD	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	7.01	1.1e-11	0.4	0.34	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	7	1.14e-11	0.58	0.34	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
STAD	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-7	1.16e-11	-0.41	-0.34	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	6.99	1.24e-11	0.4	0.34	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	6.98	1.29e-11	0.4	0.34	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	6.98	1.34e-11	0.39	0.34	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-6.97	1.35e-11	-0.56	-0.34	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
STAD	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	6.97	1.36e-11	0.4	0.34	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	6.97	1.4e-11	0.4	0.34	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	6.97	1.4e-11	0.4	0.34	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
STAD	cis	rs6011674	0.901	rs56783811	MIMAT0016888	hsa-miR-4326	-6.96	1.45e-11	-0.68	-0.33	Response to cytadine analogues (cytosine arabinoside);	chr20:63229153	chr20:63286818~63286837:+
STAD	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-6.95	1.56e-11	-0.57	-0.33	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-6.95	1.6e-11	-0.21	-0.33	Migraine;	chr10:103394332	chr10:103394301~103394322:-
STAD	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	6.95	1.61e-11	0.4	0.33	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	6.93	1.8e-11	0.4	0.33	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	6.93	1.84e-11	0.4	0.33	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-6.92	1.96e-11	-0.59	-0.33	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-6.91	1.96e-11	-0.23	-0.33	Migraine;	chr10:103315955	chr10:103394341~103394361:-
STAD	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	6.91	1.99e-11	0.4	0.33	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	6.91	2.08e-11	0.4	0.33	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	6.91	2.08e-11	0.4	0.33	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	6.91	2.09e-11	0.4	0.33	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	6.9	2.1e-11	0.4	0.33	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	6.9	2.17e-11	0.41	0.33	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	6.9	2.17e-11	0.41	0.33	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-6.9	2.19e-11	-0.23	-0.33	Migraine;	chr10:103338267	chr10:103394341~103394361:-
STAD	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	6.88	2.42e-11	0.4	0.33	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-6.88	2.44e-11	-0.21	-0.33	Migraine;	chr10:103365694	chr10:103394301~103394322:-
STAD	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	6.86	2.7e-11	0.4	0.33	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	6.84	3.05e-11	0.4	0.33	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	6.84	3.22e-11	0.4	0.33	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	6.84	3.22e-11	0.4	0.33	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-6.8	4.04e-11	-0.4	-0.33	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-6.8	4.04e-11	-0.4	-0.33	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-6.79	4.31e-11	-0.2	-0.33	Migraine;	chr10:103315955	chr10:103394301~103394322:-
STAD	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-6.78	4.52e-11	-0.5	-0.33	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-6.76	5.07e-11	-0.23	-0.33	Migraine;	chr10:103295206	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-6.76	5.07e-11	-0.23	-0.33	Migraine;	chr10:103296155	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-6.76	5.1e-11	-0.2	-0.33	Migraine;	chr10:103338267	chr10:103394301~103394322:-
STAD	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-6.73	6.32e-11	-0.53	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
STAD	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-6.73	6.32e-11	-0.53	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
STAD	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	6.72	6.69e-11	0.2	0.32	Migraine;	chr10:103263177	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-6.66	9.45e-11	-0.2	-0.32	Migraine;	chr10:103295206	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-6.66	9.45e-11	-0.2	-0.32	Migraine;	chr10:103296155	chr10:103394301~103394322:-
STAD	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	6.62	1.21e-10	0.41	0.32	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	6.61	1.26e-10	0.4	0.32	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	6.61	1.26e-10	0.4	0.32	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	6.61	1.26e-10	0.4	0.32	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	6.59	1.44e-10	0.4	0.32	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	6.59	1.46e-10	0.4	0.32	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	6.59	1.46e-10	0.4	0.32	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	6.59	1.46e-10	0.4	0.32	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
STAD	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-6.55	1.85e-10	-0.39	-0.32	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-6.54	1.95e-10	-0.22	-0.32	Migraine;	chr10:103286250	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-6.54	1.95e-10	-0.22	-0.32	Migraine;	chr10:103286932	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-6.53	2.14e-10	-0.2	-0.32	Migraine;	chr10:103286250	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-6.53	2.14e-10	-0.2	-0.32	Migraine;	chr10:103286932	chr10:103394301~103394322:-
STAD	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-6.52	2.21e-10	-0.4	-0.32	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
STAD	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	6.47	2.99e-10	0.39	0.31	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
STAD	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	6.47	3.03e-10	0.39	0.31	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
STAD	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-6.43	3.82e-10	-0.39	-0.31	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
STAD	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	6.32	7.47e-10	0.21	0.31	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
STAD	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	6.3	8.17e-10	0.39	0.31	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
STAD	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	6.27	9.52e-10	0.19	0.3	Migraine;	chr10:103236031	chr10:103394301~103394322:-
STAD	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	6.26	1.03e-09	0.19	0.3	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
STAD	cis	rs6753739	0.54	rs394452	MIMAT0014996	hsa-miR-3131	6.23	1.22e-09	0.43	0.3	Height;	chr2:219055315	chr2:219058725~219058747:-
STAD	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.23	1.24e-09	-0.36	-0.3	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
STAD	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-6.19	1.57e-09	-0.36	-0.3	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-6.18	1.65e-09	-0.19	-0.3	Migraine;	chr10:103254113	chr10:103394301~103394322:-
STAD	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-6.17	1.7e-09	-0.36	-0.3	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-6.17	1.71e-09	-0.21	-0.3	Migraine;	chr10:103254113	chr10:103394341~103394361:-
STAD	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-6.16	1.83e-09	-0.35	-0.3	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-6.16	1.83e-09	-0.35	-0.3	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-6.16	1.83e-09	-0.35	-0.3	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
STAD	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	6.15	1.89e-09	0.38	0.3	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
STAD	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	6.15	1.98e-09	0.36	0.3	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
STAD	cis	rs6753739	0.625	rs359974	MIMAT0014996	hsa-miR-3131	6.14	2e-09	0.42	0.3	Height;	chr2:219065469	chr2:219058725~219058747:-
STAD	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-6.13	2.24e-09	-0.35	-0.3	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
STAD	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-6.12	2.36e-09	-0.31	-0.3	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	6.11	2.41e-09	0.36	0.3	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	6.11	2.5e-09	0.34	0.3	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-6.09	2.79e-09	-0.31	-0.3	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
STAD	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-6.07	3.03e-09	-0.36	-0.3	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-6.05	3.46e-09	-0.34	-0.29	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-6.05	3.53e-09	-0.34	-0.29	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
STAD	cis	rs6011674	0.808	rs76337261	MIMAT0016888	hsa-miR-4326	-6.03	3.8e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63189333	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.808	rs76139001	MIMAT0016888	hsa-miR-4326	-6.03	3.8e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63189669	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.808	rs79610404	MIMAT0016888	hsa-miR-4326	-6.03	3.8e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63189895	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.808	rs80023733	MIMAT0016888	hsa-miR-4326	-6.03	3.8e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63191127	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.808	rs112813112	MIMAT0016888	hsa-miR-4326	-6.03	3.8e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63192457	chr20:63286818~63286837:+
STAD	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	6.03	3.88e-09	0.2	0.29	Migraine;	chr10:103236031	chr10:103394341~103394361:-
STAD	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-6.02	4.06e-09	-0.36	-0.29	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-5.98	5.23e-09	-0.35	-0.29	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
STAD	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	5.97	5.28e-09	0.33	0.29	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
STAD	cis	rs6011674	0.808	rs41282994	MIMAT0016888	hsa-miR-4326	-5.97	5.49e-09	-0.62	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63202740	chr20:63286818~63286837:+
STAD	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	5.95	5.92e-09	0.35	0.29	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
STAD	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	5.95	6.03e-09	0.33	0.29	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
STAD	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-5.95	6.07e-09	-0.38	-0.29	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
STAD	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-5.94	6.28e-09	-0.35	-0.29	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
STAD	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-5.94	6.4e-09	-0.3	-0.29	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
STAD	cis	rs6753739	0.673	rs17608747	MIMAT0014996	hsa-miR-3131	-5.93	6.88e-09	-0.41	-0.29	Height;	chr2:219117378	chr2:219058725~219058747:-
STAD	cis	rs6011674	0.808	rs75318321	MIMAT0016888	hsa-miR-4326	-5.92	7.15e-09	-0.63	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63213011	chr20:63286818~63286837:+
STAD	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	5.91	7.74e-09	0.34	0.29	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	5.88	8.83e-09	0.35	0.29	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
STAD	cis	rs6011674	0.731	rs113412477	MIMAT0016888	hsa-miR-4326	-5.87	9.32e-09	-0.62	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63182209	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.731	rs77857658	MIMAT0016888	hsa-miR-4326	-5.87	9.32e-09	-0.62	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63182545	chr20:63286818~63286837:+
STAD	cis	rs6011674	0.808	rs76956887	MIMAT0016888	hsa-miR-4326	-5.87	9.32e-09	-0.62	-0.29	Response to cytadine analogues (cytosine arabinoside);	chr20:63182728	chr20:63286818~63286837:+
STAD	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-5.87	9.46e-09	-0.3	-0.29	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
STAD	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	5.85	1.07e-08	0.33	0.29	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
STAD	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-5.84	1.14e-08	-0.3	-0.29	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
STAD	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-5.84	1.14e-08	-0.3	-0.29	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	5.78	1.51e-08	0.45	0.28	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
STAD	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-5.77	1.62e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
STAD	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-5.77	1.66e-08	-0.33	-0.28	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
STAD	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-5.76	1.73e-08	-0.34	-0.28	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
STAD	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-5.74	1.88e-08	-0.33	-0.28	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
STAD	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-5.74	1.88e-08	-0.33	-0.28	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
STAD	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-5.74	1.88e-08	-0.33	-0.28	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
STAD	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	5.74	1.89e-08	0.28	0.28	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
STAD	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-5.73	2.02e-08	-0.28	-0.28	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
STAD	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.72	2.14e-08	-0.32	-0.28	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-5.7	2.33e-08	-0.18	-0.28	Migraine;	chr10:103395309	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-5.7	2.33e-08	-0.18	-0.28	Migraine;	chr10:103395888	chr10:103394341~103394361:-
STAD	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-5.7	2.43e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
STAD	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-5.7	2.45e-08	-0.35	-0.28	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-5.69	2.48e-08	-0.18	-0.28	Migraine;	chr10:103389790	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	5.69	2.49e-08	0.16	0.28	Migraine;	chr10:103402122	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	5.67	2.79e-08	0.19	0.28	Migraine;	chr10:103263177	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-5.66	3e-08	-0.18	-0.28	Migraine;	chr10:103375562	chr10:103394341~103394361:-
STAD	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-5.62	3.59e-08	-0.31	-0.28	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-5.62	3.65e-08	-0.31	-0.28	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-5.62	3.69e-08	-0.32	-0.28	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-5.62	3.76e-08	-0.34	-0.28	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
STAD	cis	rs1014286	0.706	rs4851615	MIMAT0019926	hsa-miR-4772-5p	-5.6	4.08e-08	-0.28	-0.27	Serum protein levels (sST2);	chr2:102530540	chr2:102432300~102432321:+
STAD	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	5.59	4.22e-08	0.44	0.27	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
STAD	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.59	4.36e-08	-0.31	-0.27	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
STAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	5.57	4.82e-08	0.36	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
STAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	5.57	4.82e-08	0.36	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
STAD	cis	rs6753739	0.673	rs62191797	MIMAT0014996	hsa-miR-3131	-5.57	4.92e-08	-0.39	-0.27	Height;	chr2:219129221	chr2:219058725~219058747:-
STAD	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-5.55	5.22e-08	-0.23	-0.27	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
STAD	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.53	6.05e-08	-0.31	-0.27	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-5.52	6.26e-08	-0.18	-0.27	Migraine;	chr10:103358705	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-5.52	6.26e-08	-0.18	-0.27	Migraine;	chr10:103358719	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-5.52	6.33e-08	-0.18	-0.27	Migraine;	chr10:103379204	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	5.52	6.34e-08	0.17	0.27	Migraine;	chr10:103402122	chr10:103394341~103394361:-
STAD	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-5.49	7.13e-08	-0.35	-0.27	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
STAD	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	5.49	7.46e-08	0.23	0.27	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
STAD	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	5.48	7.55e-08	0.42	0.27	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
STAD	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-5.47	8.04e-08	-0.27	-0.27	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
STAD	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-5.47	8.23e-08	-0.23	-0.27	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
STAD	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-5.47	8.26e-08	-0.16	-0.27	Migraine;	chr10:103375562	chr10:103394301~103394322:-
STAD	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-5.45	8.88e-08	-0.35	-0.27	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-5.45	9.2e-08	-0.18	-0.27	Migraine;	chr10:103348698	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-5.45	9.2e-08	-0.18	-0.27	Migraine;	chr10:103353944	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-5.45	9.2e-08	-0.18	-0.27	Migraine;	chr10:103356299	chr10:103394341~103394361:-
STAD	cis	rs1014286	0.706	rs4851019	MIMAT0019926	hsa-miR-4772-5p	5.43	9.91e-08	0.27	0.27	Serum protein levels (sST2);	chr2:102561106	chr2:102432300~102432321:+
STAD	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-5.43	9.98e-08	-0.17	-0.27	Migraine;	chr10:103367521	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-5.43	9.98e-08	-0.17	-0.27	Migraine;	chr10:103367951	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	5.4	1.19e-07	0.16	0.27	Migraine;	chr10:103347713	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-5.38	1.28e-07	-0.18	-0.26	Migraine;	chr10:103292867	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-5.38	1.28e-07	-0.18	-0.26	Migraine;	chr10:103293183	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-5.38	1.28e-07	-0.18	-0.26	Migraine;	chr10:103293219	chr10:103394341~103394361:-
STAD	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-5.37	1.39e-07	-0.23	-0.26	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
STAD	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-5.35	1.51e-07	-0.17	-0.26	Migraine;	chr10:103299082	chr10:103394341~103394361:-
STAD	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-5.35	1.53e-07	-0.22	-0.26	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
STAD	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-5.33	1.66e-07	-0.15	-0.26	Migraine;	chr10:103389790	chr10:103394301~103394322:-
STAD	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	5.28	2.15e-07	0.17	0.26	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	5.27	2.26e-07	0.17	0.26	Migraine;	chr10:103367830	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-5.25	2.49e-07	-0.17	-0.26	Migraine;	chr10:103386935	chr10:103394341~103394361:-
STAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	5.25	2.49e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	5.25	2.49e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-5.24	2.62e-07	-0.15	-0.26	Migraine;	chr10:103379204	chr10:103394301~103394322:-
STAD	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-5.24	2.65e-07	-0.24	-0.26	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-5.24	2.66e-07	-0.15	-0.26	Migraine;	chr10:103358705	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-5.24	2.66e-07	-0.15	-0.26	Migraine;	chr10:103358719	chr10:103394301~103394322:-
STAD	cis	rs1014286	0.66	rs1476999	MIMAT0019926	hsa-miR-4772-5p	5.24	2.7e-07	0.26	0.26	Serum protein levels (sST2);	chr2:102515220	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.706	rs2216000	MIMAT0019926	hsa-miR-4772-5p	5.24	2.7e-07	0.26	0.26	Serum protein levels (sST2);	chr2:102516181	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-5.23	2.72e-07	-0.26	-0.26	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
STAD	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.23	2.74e-07	0.33	0.26	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-5.23	2.82e-07	-0.15	-0.26	Migraine;	chr10:103395309	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-5.23	2.82e-07	-0.15	-0.26	Migraine;	chr10:103395888	chr10:103394301~103394322:-
STAD	cis	rs1014286	0.706	rs2058656	MIMAT0019926	hsa-miR-4772-5p	5.21	3.04e-07	0.25	0.26	Serum protein levels (sST2);	chr2:102520567	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.706	rs4851612	MIMAT0019926	hsa-miR-4772-5p	5.21	3.04e-07	0.25	0.26	Serum protein levels (sST2);	chr2:102521421	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.665	rs1523204	MIMAT0019926	hsa-miR-4772-5p	5.21	3.04e-07	0.25	0.26	Serum protein levels (sST2);	chr2:102519178	chr2:102432300~102432321:+
STAD	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	5.21	3.08e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	5.21	3.08e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-5.21	3.08e-07	-0.15	-0.26	Migraine;	chr10:103307280	chr10:103394301~103394322:-
STAD	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-5.2	3.17e-07	-0.22	-0.26	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
STAD	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-5.2	3.18e-07	-0.15	-0.26	Migraine;	chr10:103348698	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-5.2	3.18e-07	-0.15	-0.26	Migraine;	chr10:103353944	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-5.2	3.18e-07	-0.15	-0.26	Migraine;	chr10:103356299	chr10:103394301~103394322:-
STAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	5.2	3.26e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	5.2	3.26e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
STAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	5.2	3.27e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	5.2	3.27e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
STAD	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	5.2	3.27e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	5.2	3.27e-07	0.34	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-5.19	3.33e-07	-0.15	-0.26	Migraine;	chr10:103299082	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-5.19	3.48e-07	-0.15	-0.26	Migraine;	chr10:103367521	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-5.19	3.48e-07	-0.15	-0.26	Migraine;	chr10:103367951	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-5.17	3.69e-07	-0.17	-0.26	Migraine;	chr10:103384531	chr10:103394341~103394361:-
STAD	cis	rs6011674	1	rs6011674	MIMAT0016888	hsa-miR-4326	5.17	3.78e-07	0.47	0.26	Response to cytadine analogues (cytosine arabinoside);	chr20:63223100	chr20:63286818~63286837:+
STAD	cis	rs1014286	0.706	rs10194822	MIMAT0019926	hsa-miR-4772-5p	-5.17	3.8e-07	-0.25	-0.26	Serum protein levels (sST2);	chr2:102549045	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.706	rs10196579	MIMAT0019926	hsa-miR-4772-5p	5.17	3.81e-07	0.26	0.26	Serum protein levels (sST2);	chr2:102553722	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.706	rs2310295	MIMAT0019926	hsa-miR-4772-5p	5.17	3.81e-07	0.26	0.26	Serum protein levels (sST2);	chr2:102554607	chr2:102432300~102432321:+
STAD	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-5.16	3.91e-07	-0.16	-0.25	Migraine;	chr10:103307280	chr10:103394341~103394361:-
STAD	cis	rs1014286	0.706	rs4851608	MIMAT0019926	hsa-miR-4772-5p	5.16	4.03e-07	0.25	0.25	Serum protein levels (sST2);	chr2:102509525	chr2:102432300~102432321:+
STAD	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	5.15	4.15e-07	0.32	0.25	Height;	chr2:206793017	chr2:206783276~206783296:-
STAD	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	5.15	4.15e-07	0.32	0.25	Height;	chr2:206793017	chr2:206783246~206783266:+
STAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	5.14	4.36e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	5.14	4.36e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
STAD	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-5.14	4.45e-07	-0.33	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-5.14	4.45e-07	-0.33	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
STAD	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	5.14	4.47e-07	0.22	0.25	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
STAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	5.11	5.07e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	5.11	5.07e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
STAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	5.11	5.21e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	5.11	5.21e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-5.1	5.3e-07	-0.15	-0.25	Migraine;	chr10:103241568	chr10:103394301~103394322:-
STAD	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-5.1	5.43e-07	-0.23	-0.25	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
STAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	5.08	5.81e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	5.08	5.81e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-5.08	5.98e-07	-0.15	-0.25	Migraine;	chr10:103386935	chr10:103394301~103394322:-
STAD	cis	rs1014286	0.73	rs2215998	MIMAT0019926	hsa-miR-4772-5p	5.07	6.14e-07	0.25	0.25	Serum protein levels (sST2);	chr2:102549584	chr2:102432300~102432321:+
STAD	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-5.07	6.24e-07	-0.15	-0.25	Migraine;	chr10:103384531	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	5.07	6.25e-07	0.16	0.25	Migraine;	chr10:103347713	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-5.06	6.52e-07	-0.15	-0.25	Migraine;	chr10:103292867	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-5.06	6.52e-07	-0.15	-0.25	Migraine;	chr10:103293183	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-5.06	6.52e-07	-0.15	-0.25	Migraine;	chr10:103293219	chr10:103394301~103394322:-
STAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	5.06	6.53e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	5.06	6.53e-07	0.33	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
STAD	cis	rs8064299	1	rs8064299	MIMAT0017994	hsa-miR-3615	-5.04	7.21e-07	-0.21	-0.25	Monocyte count;	chr17:74766507	chr17:74748663~74748683:+
STAD	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-5.04	7.34e-07	-0.16	-0.25	Migraine;	chr10:103309363	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-5.04	7.34e-07	-0.16	-0.25	Migraine;	chr10:103317367	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-5.04	7.34e-07	-0.16	-0.25	Migraine;	chr10:103319682	chr10:103394341~103394361:-
STAD	cis	rs1014286	0.706	rs6761291	MIMAT0019926	hsa-miR-4772-5p	5.01	8.4e-07	0.25	0.25	Serum protein levels (sST2);	chr2:102538610	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.641	rs10172553	MIMAT0019926	hsa-miR-4772-5p	5	8.61e-07	0.25	0.25	Serum protein levels (sST2);	chr2:102536516	chr2:102432300~102432321:+
STAD	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-4.99	9.1e-07	-0.15	-0.25	Migraine;	chr10:103309363	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-4.99	9.1e-07	-0.15	-0.25	Migraine;	chr10:103317367	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-4.99	9.1e-07	-0.15	-0.25	Migraine;	chr10:103319682	chr10:103394301~103394322:-
STAD	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-4.99	9.38e-07	-0.23	-0.25	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	4.98	9.56e-07	0.15	0.25	Migraine;	chr10:103367830	chr10:103394301~103394322:-
STAD	cis	rs78314980	0.557	rs41265179	MIMAT0022491	hsa-miR-5698	4.98	9.6e-07	0.71	0.25	Itch intensity from mosquito bite adjusted by bite size;	chr1:153629352	chr1:154104562~154104583:-
STAD	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-4.97	9.94e-07	-0.16	-0.25	Migraine;	chr10:103305652	chr10:103394341~103394361:-
STAD	cis	rs75358501	0.688	rs28365797	MIMAT0014994	hsa-miR-3130-3p	4.96	1.08e-06	0.32	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.688	rs28365797	MIMAT0014994_1	hsa-miR-3130-3p	4.96	1.08e-06	0.32	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.11e-06	-0.16	-0.24	Migraine;	chr10:103299551	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.13e-06	-0.16	-0.24	Migraine;	chr10:103297804	chr10:103394341~103394361:-
STAD	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	4.93	1.22e-06	0.36	0.24	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-4.92	1.3e-06	-0.14	-0.24	Migraine;	chr10:103297804	chr10:103394301~103394322:-
STAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-4.91	1.35e-06	-0.32	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-4.91	1.35e-06	-0.32	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
STAD	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-4.91	1.38e-06	-0.25	-0.24	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
STAD	cis	rs75358501	0.636	rs957414	MIMAT0014994	hsa-miR-3130-3p	4.9	1.39e-06	0.32	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs957414	MIMAT0014994_1	hsa-miR-3130-3p	4.9	1.39e-06	0.32	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783277~206783297:+
STAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	4.89	1.47e-06	0.32	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	4.89	1.47e-06	0.32	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
STAD	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.54e-06	-0.16	-0.24	Migraine;	chr10:103241568	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-4.88	1.57e-06	-0.14	-0.24	Migraine;	chr10:103299551	chr10:103394301~103394322:-
STAD	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-4.87	1.67e-06	-0.16	-0.24	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
STAD	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	4.85	1.77e-06	0.2	0.24	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	4.85	1.78e-06	0.14	0.24	Migraine;	chr10:103238157	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	4.84	1.85e-06	0.16	0.24	Migraine;	chr10:103238157	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-4.83	2.02e-06	-0.15	-0.24	Migraine;	chr10:103279822	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-4.82	2.02e-06	-0.14	-0.24	Migraine;	chr10:103273871	chr10:103394301~103394322:-
STAD	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-4.82	2.05e-06	-0.34	-0.24	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-4.82	2.06e-06	-0.34	-0.24	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-4.81	2.18e-06	-0.35	-0.24	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
STAD	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-4.79	2.42e-06	-0.33	-0.24	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
STAD	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-4.78	2.54e-06	-0.14	-0.24	Migraine;	chr10:103305652	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4.78	2.55e-06	-0.16	-0.24	Migraine;	chr10:103273871	chr10:103394341~103394361:-
STAD	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-4.76	2.78e-06	-0.34	-0.24	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-4.75	2.83e-06	-0.34	-0.24	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-4.73	3.2e-06	-0.2	-0.23	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-4.72	3.3e-06	-0.16	-0.23	Migraine;	chr10:103279822	chr10:103394341~103394361:-
STAD	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	4.71	3.43e-06	0.2	0.23	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
STAD	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-4.71	3.51e-06	-0.15	-0.23	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
STAD	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-4.7	3.6e-06	-0.24	-0.23	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-4.7	3.6e-06	-0.24	-0.23	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	4.7	3.69e-06	0.2	0.23	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	4.7	3.69e-06	0.2	0.23	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	4.69	3.86e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-4.68	3.98e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	4.68	4.05e-06	0.14	0.23	Migraine;	chr10:103261506	chr10:103394301~103394322:-
STAD	cis	rs7894407	0.856	rs7093667	MIMAT0022727	hsa-miR-1307-5p	-4.67	4.12e-06	-0.17	-0.23	White matter hyperintensity burden;	chr10:103320818	chr10:103394341~103394361:-
STAD	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	4.67	4.16e-06	0.26	0.23	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
STAD	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-4.67	4.2e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-4.66	4.46e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
STAD	cis	rs950880	0.542	rs1420091	MIMAT0019927	hsa-miR-4772-3p	4.65	4.66e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102300774	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	4.65	4.66e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	4.64	4.79e-06	0.2	0.23	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
STAD	cis	rs7894407	0.892	rs10883859	MIMAT0022727	hsa-miR-1307-5p	4.64	4.87e-06	0.16	0.23	White matter hyperintensity burden;	chr10:103368377	chr10:103394341~103394361:-
STAD	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-4.63	4.92e-06	-0.19	-0.23	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
STAD	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	4.63	4.95e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	4.63	4.95e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
STAD	cis	rs17639215	0.55	rs9679297	MIMAT0019926	hsa-miR-4772-5p	4.63	4.97e-06	0.3	0.23	Serum protein levels (sST2);	chr2:102298109	chr2:102432300~102432321:+
STAD	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-4.63	5.01e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-4.62	5.15e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-4.62	5.15e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-4.62	5.18e-06	-0.26	-0.23	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	4.62	5.31e-06	0.27	0.23	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	4.62	5.31e-06	0.27	0.23	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
STAD	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	4.62	5.35e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
STAD	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	4.62	5.35e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	4.62	5.35e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.43e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.49e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
STAD	cis	rs2564921	0.73	rs2564929	MIMAT0000414	hsa-let-7g-5p	-4.61	5.61e-06	-0.23	-0.23	Height;	chr3:53084188	chr3:52268336~52268357:-
STAD	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.61e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.69e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.69e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
STAD	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	4.6	5.71e-06	0.15	0.23	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
STAD	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.87e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.87e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.87e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-4.6	5.87e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.934	rs4655635	MIMAT0014979	hsa-miR-3117-3p	-4.59	6.15e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66602557	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-4.58	6.16e-06	-0.14	-0.23	Migraine;	chr10:103284207	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-4.58	6.16e-06	-0.14	-0.23	Migraine;	chr10:103283532	chr10:103394301~103394322:-
STAD	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	4.58	6.19e-06	0.23	0.23	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	4.58	6.41e-06	0.26	0.23	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
STAD	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-4.56	6.81e-06	-0.14	-0.23	Migraine;	chr10:103270083	chr10:103394301~103394322:-
STAD	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	4.56	6.82e-06	0.25	0.23	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
STAD	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-4.55	7.09e-06	-0.32	-0.23	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-4.55	7.11e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	4.55	7.14e-06	0.26	0.23	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	4.55	7.14e-06	0.26	0.23	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	4.55	7.14e-06	0.26	0.23	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
STAD	cis	rs7894407	0.856	rs10883855	MIMAT0022727	hsa-miR-1307-5p	-4.55	7.18e-06	-0.16	-0.23	White matter hyperintensity burden;	chr10:103332690	chr10:103394341~103394361:-
STAD	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	4.55	7.25e-06	0.26	0.23	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
STAD	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.55	7.34e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
STAD	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-4.55	7.37e-06	-0.13	-0.23	Migraine;	chr10:103273985	chr10:103394301~103394322:-
STAD	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	4.54	7.38e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	4.54	7.42e-06	0.32	0.23	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	4.54	7.43e-06	0.19	0.23	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-4.53	7.82e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-4.53	7.82e-06	-0.33	-0.23	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	4.53	7.9e-06	0.26	0.23	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	4.53	8.02e-06	0.25	0.23	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
STAD	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-4.52	8.08e-06	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	4.52	8.14e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
STAD	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-4.51	8.48e-06	-0.13	-0.22	Migraine;	chr10:103279291	chr10:103394301~103394322:-
STAD	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-4.51	8.65e-06	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	4.51	8.69e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-4.51	8.69e-06	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	4.51	8.7e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
STAD	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	4.51	8.7e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	4.51	8.7e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	4.51	8.7e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	4.51	8.74e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.621	rs3750604	MIMAT0026738	hsa-miR-1287-3p	4.51	8.75e-06	0.2	0.22	Metabolite levels;	chr10:98415824	chr10:98395232~98395253:-
STAD	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
STAD	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
STAD	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	4.5	8.83e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	4.5	8.85e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	4.5	8.87e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	4.5	8.93e-06	0.32	0.22	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
STAD	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-4.5	9.11e-06	-0.13	-0.22	Migraine;	chr10:103273258	chr10:103394301~103394322:-
STAD	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	4.49	9.26e-06	0.19	0.22	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-4.49	9.38e-06	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-4.48	9.69e-06	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	4.48	9.77e-06	0.19	0.22	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
STAD	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	4.48	1e-05	0.19	0.22	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	4.47	1.05e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	4.46	1.08e-05	0.19	0.22	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
STAD	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-4.46	1.08e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	4.46	1.09e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-4.46	1.1e-05	-0.15	-0.22	Migraine;	chr10:103283532	chr10:103394341~103394361:-
STAD	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	4.45	1.1e-05	0.19	0.22	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-4.45	1.12e-05	-0.31	-0.22	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-4.45	1.15e-05	-0.13	-0.22	Migraine;	chr10:103262005	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	4.45	1.15e-05	0.15	0.22	Migraine;	chr10:103240612	chr10:103394341~103394361:-
STAD	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	4.44	1.17e-05	0.25	0.22	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
STAD	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	4.44	1.18e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	4.43	1.22e-05	0.25	0.22	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	4.43	1.22e-05	0.25	0.22	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
STAD	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	4.43	1.25e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	4.43	1.25e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	4.43	1.25e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4.43	1.26e-05	0.15	0.22	Migraine;	chr10:103241753	chr10:103394341~103394361:-
STAD	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	4.43	1.26e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-4.42	1.27e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
STAD	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	4.42	1.27e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
STAD	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	4.42	1.29e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	4.42	1.29e-05	0.25	0.22	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	4.42	1.29e-05	0.25	0.22	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	4.42	1.29e-05	0.25	0.22	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	4.42	1.29e-05	0.25	0.22	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	4.42	1.29e-05	0.25	0.22	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
STAD	cis	rs7894407	1	rs7894407	MIMAT0022727	hsa-miR-1307-5p	4.42	1.3e-05	0.16	0.22	White matter hyperintensity burden;	chr10:103416422	chr10:103394341~103394361:-
STAD	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.33e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
STAD	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	4.41	1.37e-05	0.2	0.22	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
STAD	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.38e-05	-0.22	-0.22	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	4.4	1.39e-05	0.25	0.22	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
STAD	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	4.4	1.4e-05	0.18	0.22	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.43e-05	-0.22	-0.22	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.43e-05	-0.22	-0.22	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.43e-05	-0.22	-0.22	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.555	rs2296433	MIMAT0026738	hsa-miR-1287-3p	4.39	1.45e-05	0.19	0.22	Metabolite levels;	chr10:98424305	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.555	rs2296432	MIMAT0026738	hsa-miR-1287-3p	4.39	1.45e-05	0.19	0.22	Metabolite levels;	chr10:98424306	chr10:98395232~98395253:-
STAD	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-4.39	1.49e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.52e-05	-0.22	-0.22	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-4.38	1.54e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
STAD	cis	rs75358501	0.636	rs12478466	MIMAT0014994	hsa-miR-3130-3p	4.38	1.54e-05	0.3	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs12478466	MIMAT0014994_1	hsa-miR-3130-3p	4.38	1.54e-05	0.3	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783277~206783297:+
STAD	cis	rs10851411	0.697	rs8039240	MIMAT0026623	hsa-miR-627-3p	-4.38	1.55e-05	-0.36	-0.22	Glucose homeostasis traits;	chr15:42525379	chr15:42199593~42199612:-
STAD	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	4.38	1.56e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.37	1.59e-05	0.18	0.22	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
STAD	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	4.37	1.59e-05	0.2	0.22	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
STAD	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	4.37	1.59e-05	0.2	0.22	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	4.37	1.6e-05	0.13	0.22	Migraine;	chr10:103240612	chr10:103394301~103394322:-
STAD	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	4.37	1.61e-05	0.13	0.22	Migraine;	chr10:103244344	chr10:103394301~103394322:-
STAD	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	4.36	1.66e-05	0.25	0.22	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
STAD	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	4.36	1.66e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	4.36	1.66e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
STAD	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	4.36	1.66e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	4.36	1.66e-05	0.25	0.22	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
STAD	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	4.36	1.68e-05	0.14	0.22	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
STAD	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-4.35	1.73e-05	-0.31	-0.22	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-4.35	1.76e-05	-0.18	-0.22	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
STAD	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.35	1.76e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.35	1.76e-05	-0.32	-0.22	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-4.34	1.79e-05	-0.22	-0.22	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	4.34	1.85e-05	0.18	0.22	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.898	rs2483704	MIMAT0014979	hsa-miR-3117-3p	4.33	1.88e-05	0.31	0.22	Presence of antiphospholipid antibodies;	chr1:66729670	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	4.33	1.89e-05	0.14	0.22	Migraine;	chr10:103244344	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-4.33	1.93e-05	-0.15	-0.22	Migraine;	chr10:103284207	chr10:103394341~103394361:-
STAD	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	4.33	1.94e-05	0.24	0.22	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	4.32	1.96e-05	0.24	0.22	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
STAD	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	4.32	1.96e-05	0.18	0.22	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
STAD	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.99e-05	-0.31	-0.22	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
STAD	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.99e-05	-0.31	-0.22	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-4.32	2.03e-05	-0.22	-0.22	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	4.32	2.03e-05	0.25	0.22	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-4.31	2.07e-05	-0.24	-0.21	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
STAD	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	4.31	2.09e-05	0.14	0.21	Migraine;	chr10:103261506	chr10:103394341~103394361:-
STAD	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	4.31	2.09e-05	0.3	0.21	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
STAD	cis	rs7851726	0.668	rs10821390	MIMAT0019208	hsa-miR-3074-5p	-4.31	2.11e-05	-0.17	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94743305	chr9:95086063~95086083:-
STAD	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	4.3	2.13e-05	0.2	0.21	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
STAD	cis	rs10851411	0.697	rs12439377	MIMAT0026623	hsa-miR-627-3p	-4.3	2.14e-05	-0.34	-0.21	Glucose homeostasis traits;	chr15:42569164	chr15:42199593~42199612:-
STAD	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.3	2.14e-05	0.18	0.21	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.3	2.15e-05	0.18	0.21	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
STAD	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-4.3	2.21e-05	-0.13	-0.21	Migraine;	chr10:103278698	chr10:103394301~103394322:-
STAD	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	4.29	2.22e-05	0.31	0.21	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.26e-05	-0.29	-0.21	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.29	2.27e-05	0.18	0.21	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
STAD	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.28e-05	-0.31	-0.21	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.29	2.29e-05	0.18	0.21	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
STAD	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	4.29	2.3e-05	0.2	0.21	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
STAD	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-4.29	2.3e-05	-0.22	-0.21	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
STAD	cis	rs7851726	0.624	rs10993344	MIMAT0019208	hsa-miR-3074-5p	-4.28	2.33e-05	-0.17	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94785653	chr9:95086063~95086083:-
STAD	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-4.28	2.36e-05	-0.31	-0.21	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	4.28	2.39e-05	0.24	0.21	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	4.28	2.39e-05	0.24	0.21	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	4.28	2.4e-05	0.24	0.21	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
STAD	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-4.27	2.42e-05	-0.31	-0.21	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	4.27	2.49e-05	0.18	0.21	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	4.27	2.49e-05	0.18	0.21	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.27	2.51e-05	0.18	0.21	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
STAD	cis	rs7851726	0.565	rs10821413	MIMAT0019208	hsa-miR-3074-5p	-4.26	2.54e-05	-0.18	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94907034	chr9:95086063~95086083:-
STAD	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-4.26	2.55e-05	-0.18	-0.21	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
STAD	cis	rs8064299	0.655	rs2305214	MIMAT0017994	hsa-miR-3615	-4.25	2.65e-05	-0.18	-0.21	Monocyte count;	chr17:74772831	chr17:74748663~74748683:+
STAD	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-4.25	2.66e-05	-0.21	-0.21	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-4.25	2.66e-05	-0.14	-0.21	Migraine;	chr10:103270083	chr10:103394341~103394361:-
STAD	cis	rs10851411	0.697	rs41315252	MIMAT0026623	hsa-miR-627-3p	-4.25	2.67e-05	-0.35	-0.21	Glucose homeostasis traits;	chr15:42545299	chr15:42199593~42199612:-
STAD	cis	rs6681460	0.898	rs536527	MIMAT0014979	hsa-miR-3117-3p	-4.25	2.7e-05	-0.3	-0.21	Presence of antiphospholipid antibodies;	chr1:66728110	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-4.25	2.72e-05	-0.18	-0.21	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
STAD	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	4.25	2.74e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-4.25	2.74e-05	-0.21	-0.21	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
STAD	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-4.24	2.75e-05	-0.14	-0.21	Migraine;	chr10:103262005	chr10:103394341~103394361:-
STAD	cis	rs10851411	0.606	rs11635889	MIMAT0026623	hsa-miR-627-3p	-4.24	2.78e-05	-0.35	-0.21	Glucose homeostasis traits;	chr15:42526789	chr15:42199593~42199612:-
STAD	cis	rs10851411	0.697	rs11630625	MIMAT0026623	hsa-miR-627-3p	-4.24	2.78e-05	-0.35	-0.21	Glucose homeostasis traits;	chr15:42526977	chr15:42199593~42199612:-
STAD	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	4.24	2.81e-05	0.3	0.21	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
STAD	cis	rs7851726	0.628	rs12344211	MIMAT0019208	hsa-miR-3074-5p	4.23	2.87e-05	0.18	0.21	Urinary albumin-to-creatinine ratio;	chr9:94928822	chr9:95086063~95086083:-
STAD	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-4.23	2.92e-05	-0.14	-0.21	Migraine;	chr10:103273985	chr10:103394341~103394361:-
STAD	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	4.23	2.93e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.96e-05	-0.3	-0.21	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
STAD	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	4.23	2.96e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	4.22	2.99e-05	0.17	0.21	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	4.22	2.99e-05	0.17	0.21	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
STAD	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	4.22	3.06e-05	0.18	0.21	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
STAD	cis	rs7851726	0.628	rs12338409	MIMAT0019208	hsa-miR-3074-5p	4.21	3.15e-05	0.17	0.21	Urinary albumin-to-creatinine ratio;	chr9:94928807	chr9:95086063~95086083:-
STAD	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	4.21	3.17e-05	0.13	0.21	Migraine;	chr10:103237257	chr10:103394301~103394322:-
STAD	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.24e-05	-0.21	-0.21	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	4.2	3.27e-05	0.3	0.21	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.31e-05	-0.13	-0.21	Migraine;	chr10:103284400	chr10:103394301~103394322:-
STAD	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	4.2	3.39e-05	0.19	0.21	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
STAD	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	4.2	3.39e-05	0.19	0.21	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
STAD	cis	rs7851726	0.69	rs11788697	MIMAT0019208	hsa-miR-3074-5p	-4.2	3.39e-05	-0.17	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94823083	chr9:95086063~95086083:-
STAD	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	4.19	3.43e-05	0.24	0.21	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
STAD	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.19	3.45e-05	0.14	0.21	Migraine;	chr10:103248169	chr10:103394341~103394361:-
STAD	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	4.19	3.45e-05	0.14	0.21	Migraine;	chr10:103237257	chr10:103394341~103394361:-
STAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	4.19	3.49e-05	0.3	0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
STAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	4.19	3.49e-05	0.3	0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
STAD	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	4.19	3.52e-05	0.19	0.21	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
STAD	cis	rs10851411	0.697	rs11636209	MIMAT0026623	hsa-miR-627-3p	-4.19	3.53e-05	-0.35	-0.21	Glucose homeostasis traits;	chr15:42495909	chr15:42199593~42199612:-
STAD	cis	rs10851411	0.697	rs113979838	MIMAT0026623	hsa-miR-627-3p	-4.19	3.53e-05	-0.35	-0.21	Glucose homeostasis traits;	chr15:42500155	chr15:42199593~42199612:-
STAD	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	4.19	3.54e-05	0.29	0.21	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.57e-05	-0.21	-0.21	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
STAD	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-4.18	3.6e-05	-0.14	-0.21	Migraine;	chr10:103273258	chr10:103394341~103394361:-
STAD	cis	rs8064299	0.655	rs895691	MIMAT0017994	hsa-miR-3615	-4.18	3.61e-05	-0.18	-0.21	Monocyte count;	chr17:74770161	chr17:74748663~74748683:+
STAD	cis	rs2581828	0.646	rs2564944	MIMAT0000414	hsa-let-7g-5p	4.18	3.65e-05	0.22	0.21	Crohn's disease;	chr3:53114439	chr3:52268336~52268357:-
STAD	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.65e-05	-0.21	-0.21	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.65e-05	-0.21	-0.21	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.2	-0.21	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
STAD	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-4.17	3.71e-05	-0.19	-0.21	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
STAD	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	4.17	3.71e-05	0.14	0.21	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
STAD	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	4.17	3.72e-05	0.18	0.21	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	4.17	3.72e-05	0.18	0.21	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	4.17	3.72e-05	0.18	0.21	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
STAD	cis	rs10021731	1	rs13104222	MIMAT0003242	hsa-miR-577	4.17	3.73e-05	0.19	0.21	Optic disc area;	chr4:114549757	chr4:114656774~114656794:+
STAD	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-4.17	3.74e-05	-0.26	-0.21	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	4.17	3.79e-05	0.24	0.21	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	4.16	3.86e-05	0.24	0.21	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	4.16	3.86e-05	0.24	0.21	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	4.16	3.91e-05	0.24	0.21	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4.16	3.96e-05	0.17	0.21	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
STAD	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-4.16	3.99e-05	-0.14	-0.21	Migraine;	chr10:103279291	chr10:103394341~103394361:-
STAD	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	4.15	4.05e-05	0.3	0.21	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.15	4.13e-05	0.17	0.21	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
STAD	cis	rs10021731	1	rs4834419	MIMAT0003242	hsa-miR-577	4.15	4.16e-05	0.19	0.21	Optic disc area;	chr4:114548870	chr4:114656774~114656794:+
STAD	cis	rs10021731	1	rs1599323	MIMAT0003242	hsa-miR-577	4.15	4.16e-05	0.19	0.21	Optic disc area;	chr4:114549176	chr4:114656774~114656794:+
STAD	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
STAD	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.26e-05	-0.2	-0.21	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	4.13	4.36e-05	0.17	0.21	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	4.13	4.37e-05	0.24	0.21	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
STAD	cis	rs10021731	1	rs6533801	MIMAT0003242	hsa-miR-577	4.13	4.45e-05	0.19	0.21	Optic disc area;	chr4:114553199	chr4:114656774~114656794:+
STAD	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-4.13	4.53e-05	-0.29	-0.21	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	4.12	4.63e-05	0.21	0.21	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	4.12	4.63e-05	0.17	0.21	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
STAD	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	4.12	4.64e-05	0.12	0.21	Migraine;	chr10:103241753	chr10:103394301~103394322:-
STAD	cis	rs6681460	1	rs7532173	MIMAT0014979	hsa-miR-3117-3p	-4.12	4.65e-05	-0.3	-0.21	Presence of antiphospholipid antibodies;	chr1:66620428	chr1:66628485~66628505:+
STAD	cis	rs10021731	0.809	rs35733223	MIMAT0003242	hsa-miR-577	4.12	4.65e-05	0.19	0.21	Optic disc area;	chr4:114566454	chr4:114656774~114656794:+
STAD	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	4.12	4.71e-05	0.12	0.21	Migraine;	chr10:103248169	chr10:103394301~103394322:-
STAD	cis	rs7851726	0.628	rs4744412	MIMAT0019208	hsa-miR-3074-5p	4.11	4.84e-05	0.17	0.21	Urinary albumin-to-creatinine ratio;	chr9:94928219	chr9:95086063~95086083:-
STAD	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-4.11	4.84e-05	-0.29	-0.21	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	4.1	4.97e-05	0.17	0.2	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
STAD	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-4.09	5.18e-05	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
STAD	cis	rs10851411	0.697	rs17709867	MIMAT0026623	hsa-miR-627-3p	-4.09	5.18e-05	-0.34	-0.2	Glucose homeostasis traits;	chr15:42508569	chr15:42199593~42199612:-
STAD	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	4.08	5.43e-05	0.29	0.2	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.08	5.55e-05	0.13	0.2	Migraine;	chr10:103249329	chr10:103394341~103394361:-
STAD	cis	rs10851411	0.697	rs72711767	MIMAT0026623	hsa-miR-627-3p	-4.07	5.6e-05	-0.33	-0.2	Glucose homeostasis traits;	chr15:42551772	chr15:42199593~42199612:-
STAD	cis	rs10851411	0.697	rs56069741	MIMAT0026623	hsa-miR-627-3p	-4.07	5.6e-05	-0.33	-0.2	Glucose homeostasis traits;	chr15:42562859	chr15:42199593~42199612:-
STAD	cis	rs10851411	0.542	rs10454692	MIMAT0026623	hsa-miR-627-3p	-4.07	5.6e-05	-0.33	-0.2	Glucose homeostasis traits;	chr15:42564857	chr15:42199593~42199612:-
STAD	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-4.07	5.64e-05	-0.31	-0.2	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
STAD	cis	rs10851411	0.697	rs17766258	MIMAT0026623	hsa-miR-627-3p	4.07	5.64e-05	0.35	0.2	Glucose homeostasis traits;	chr15:42492939	chr15:42199593~42199612:-
STAD	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-4.07	5.66e-05	-0.22	-0.2	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
STAD	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-4.07	5.68e-05	-0.29	-0.2	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
STAD	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-4.07	5.71e-05	-0.2	-0.2	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
STAD	cis	rs7851726	0.69	rs10821404	MIMAT0019208	hsa-miR-3074-5p	-4.07	5.78e-05	-0.17	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94834583	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.69	rs4743969	MIMAT0019208	hsa-miR-3074-5p	-4.07	5.78e-05	-0.17	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94836684	chr9:95086063~95086083:-
STAD	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-4.07	5.82e-05	-0.13	-0.2	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
STAD	cis	rs1466535	1	rs1466535	MIMAT0000082	hsa-miR-26a-5p	4.06	5.83e-05	0.13	0.2	Abdominal aortic aneurysm;	chr12:57140687	chr12:57824658~57824679:-
STAD	cis	rs1466535	1	rs1466535	MIMAT0000082_1	hsa-miR-26a-5p	4.06	5.83e-05	0.13	0.2	Abdominal aortic aneurysm;	chr12:57140687	chr3:37969413~37969434:+
STAD	cis	rs10021731	1	rs10021731	MIMAT0003242	hsa-miR-577	4.06	5.98e-05	0.19	0.2	Optic disc area;	chr4:114560759	chr4:114656774~114656794:+
STAD	cis	rs8064299	0.655	rs11655219	MIMAT0017994	hsa-miR-3615	-4.06	6e-05	-0.18	-0.2	Monocyte count;	chr17:74775154	chr17:74748663~74748683:+
STAD	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.16e-05	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs7547866	MIMAT0014979	hsa-miR-3117-3p	4.05	6.19e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66566241	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs7525509	MIMAT0014979	hsa-miR-3117-3p	4.05	6.19e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66566285	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs1156618	MIMAT0014979	hsa-miR-3117-3p	4.05	6.29e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66565881	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	4.05	6.29e-05	0.12	0.2	Migraine;	chr10:103249329	chr10:103394301~103394322:-
STAD	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-4.04	6.33e-05	-0.2	-0.2	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-4.04	6.33e-05	-0.2	-0.2	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
STAD	cis	rs7851726	0.714	rs1867102	MIMAT0019208	hsa-miR-3074-5p	-4.04	6.36e-05	-0.17	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94865485	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.624	rs12347649	MIMAT0019208	hsa-miR-3074-5p	-4.04	6.43e-05	-0.17	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94901286	chr9:95086063~95086083:-
STAD	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-4.04	6.49e-05	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
STAD	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	4.04	6.54e-05	0.19	0.2	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
STAD	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	4.03	6.63e-05	0.3	0.2	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
STAD	cis	rs9847710	0.967	rs2564931	MIMAT0000414	hsa-let-7g-5p	4.03	6.64e-05	0.2	0.2	Ulcerative colitis;	chr3:52986543	chr3:52268336~52268357:-
STAD	cis	rs10021731	1	rs11098258	MIMAT0003242	hsa-miR-577	4.03	6.74e-05	0.19	0.2	Optic disc area;	chr4:114564528	chr4:114656774~114656794:+
STAD	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-4.03	6.81e-05	-0.19	-0.2	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
STAD	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-4.03	6.82e-05	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	4.03	6.86e-05	0.28	0.2	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-4.02	6.88e-05	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
STAD	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-4.02	7.01e-05	-0.13	-0.2	Migraine;	chr10:103278698	chr10:103394341~103394361:-
STAD	cis	rs10851411	0.657	rs1048571	MIMAT0026623	hsa-miR-627-3p	-4.01	7.23e-05	-0.33	-0.2	Glucose homeostasis traits;	chr15:42569826	chr15:42199593~42199612:-
STAD	cis	rs10851411	0.697	rs62019315	MIMAT0026623	hsa-miR-627-3p	-4.01	7.23e-05	-0.33	-0.2	Glucose homeostasis traits;	chr15:42571344	chr15:42199593~42199612:-
STAD	cis	rs1165668	0.816	rs1866069	MIMAT0018197	hsa-miR-3922-3p	-4.01	7.35e-05	-0.22	-0.2	Coronary heart disease (SNP X SNP interaction);	chr12:103916767	chr12:104591694~104591715:+
STAD	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	4.01	7.39e-05	0.16	0.2	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-4	7.51e-05	-0.2	-0.2	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-4	7.51e-05	-0.2	-0.2	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	4	7.56e-05	0.23	0.2	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	4	7.56e-05	0.23	0.2	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	4	7.69e-05	0.17	0.2	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	4	7.69e-05	0.17	0.2	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	4	7.69e-05	0.17	0.2	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	4	7.69e-05	0.17	0.2	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	4	7.69e-05	0.17	0.2	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
STAD	cis	rs10993397	0.528	rs356665	MIMAT0019208	hsa-miR-3074-5p	-4	7.69e-05	-0.16	-0.2	Polycystic ovary syndrome;	chr9:95298349	chr9:95086063~95086083:-
STAD	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-4	7.7e-05	-0.27	-0.2	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	4	7.75e-05	0.28	0.2	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
STAD	cis	rs6724465	1	rs56345933	MIMAT0014996	hsa-miR-3131	-3.99	7.88e-05	-0.33	-0.2	Height;	chr2:219049013	chr2:219058725~219058747:-
STAD	cis	rs6724465	1	rs56006038	MIMAT0014996	hsa-miR-3131	-3.99	7.88e-05	-0.33	-0.2	Height;	chr2:219049115	chr2:219058725~219058747:-
STAD	cis	rs4851551	0.543	rs1997503	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.89e-05	-0.28	-0.2	Blood protein levels;	chr2:102192775	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	3.99	7.91e-05	0.17	0.2	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	3.99	7.91e-05	0.17	0.2	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
STAD	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-3.99	7.91e-05	-0.18	-0.2	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
STAD	cis	rs4960162	1	rs4960162	MIMAT0022472	hsa-miR-5683	3.99	8.07e-05	0.25	0.2	Night sleep phenotypes;	chr6:6065527	chr6:6169343~6169366:+
STAD	cis	rs6724465	1	rs13404123	MIMAT0014996	hsa-miR-3131	3.98	8.13e-05	0.32	0.2	Height;	chr2:219052075	chr2:219058725~219058747:-
STAD	cis	rs6724465	1	rs72967942	MIMAT0014996	hsa-miR-3131	-3.98	8.15e-05	-0.32	-0.2	Height;	chr2:219052800	chr2:219058725~219058747:-
STAD	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	3.98	8.19e-05	0.27	0.2	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs7547794	MIMAT0014979	hsa-miR-3117-3p	3.98	8.26e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66566195	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs7547857	MIMAT0014979	hsa-miR-3117-3p	3.98	8.26e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66566207	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	3.97	8.43e-05	0.28	0.2	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
STAD	cis	rs6724465	1	rs10177466	MIMAT0014996	hsa-miR-3131	-3.97	8.45e-05	-0.33	-0.2	Height;	chr2:219046266	chr2:219058725~219058747:-
STAD	cis	rs10021731	0.83	rs17622401	MIMAT0003242	hsa-miR-577	3.97	8.51e-05	0.19	0.2	Optic disc area;	chr4:114571551	chr4:114656774~114656794:+
STAD	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.53e-05	-0.2	-0.2	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.53e-05	-0.2	-0.2	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.53e-05	-0.2	-0.2	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.53e-05	-0.2	-0.2	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.53e-05	-0.2	-0.2	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	3.97	8.56e-05	0.28	0.2	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
STAD	cis	rs9662615	0.569	rs1068683	MIMAT0003215	hsa-miR-552-3p	-3.97	8.57e-05	-0.21	-0.2	Response to lithium treatment in bipolar disorder;	chr1:34117774	chr1:34669614~34669634:-
STAD	cis	rs1165668	0.816	rs1866072	MIMAT0018197	hsa-miR-3922-3p	3.97	8.67e-05	0.22	0.2	Coronary heart disease (SNP X SNP interaction);	chr12:103916928	chr12:104591694~104591715:+
STAD	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-3.97	8.7e-05	-0.13	-0.2	Migraine;	chr10:103284400	chr10:103394341~103394361:-
STAD	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	3.96	8.9e-05	0.17	0.2	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
STAD	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.91e-05	-0.2	-0.2	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.91e-05	-0.2	-0.2	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.91e-05	-0.2	-0.2	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.549	rs6680968	MIMAT0014979	hsa-miR-3117-3p	3.96	8.98e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66568978	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs11208908	MIMAT0014979	hsa-miR-3117-3p	3.96	8.98e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66570953	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.549	rs4655620	MIMAT0014979	hsa-miR-3117-3p	3.96	8.98e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66571511	chr1:66628485~66628505:+
STAD	cis	rs6681460	0.528	rs10889629	MIMAT0014979	hsa-miR-3117-3p	3.96	9.05e-05	0.26	0.2	Presence of antiphospholipid antibodies;	chr1:66566415	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	3.96	9.1e-05	0.17	0.2	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
STAD	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	3.95	9.14e-05	0.29	0.2	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
STAD	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	3.95	9.22e-05	0.16	0.2	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	3.95	9.22e-05	0.16	0.2	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	3.95	9.22e-05	0.16	0.2	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	3.95	9.22e-05	0.16	0.2	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	3.95	9.22e-05	0.16	0.2	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	3.95	9.23e-05	0.16	0.2	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	3.95	9.28e-05	0.21	0.2	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
STAD	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	3.95	9.34e-05	0.22	0.2	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
STAD	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-3.94	9.54e-05	-0.16	-0.2	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
STAD	cis	rs9662615	0.593	rs771119	MIMAT0003215	hsa-miR-552-3p	-3.94	9.6e-05	-0.21	-0.2	Response to lithium treatment in bipolar disorder;	chr1:34113012	chr1:34669614~34669634:-
STAD	cis	rs9662615	0.618	rs771121	MIMAT0003215	hsa-miR-552-3p	-3.94	9.6e-05	-0.21	-0.2	Response to lithium treatment in bipolar disorder;	chr1:34114133	chr1:34669614~34669634:-
STAD	cis	rs9662615	0.593	rs770872	MIMAT0003215	hsa-miR-552-3p	-3.94	9.6e-05	-0.21	-0.2	Response to lithium treatment in bipolar disorder;	chr1:34115374	chr1:34669614~34669634:-
STAD	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.64e-05	-0.3	-0.2	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.75e-05	-0.25	-0.2	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.75e-05	-0.25	-0.2	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.75e-05	-0.25	-0.2	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
STAD	cis	rs8064299	0.632	rs750018	MIMAT0017994	hsa-miR-3615	-3.94	9.83e-05	-0.17	-0.2	Monocyte count;	chr17:74775498	chr17:74748663~74748683:+
STAD	cis	rs6681460	0.898	rs1032634	MIMAT0014979	hsa-miR-3117-3p	3.93	9.88e-05	0.28	0.2	Presence of antiphospholipid antibodies;	chr1:66729509	chr1:66628485~66628505:+
STAD	cis	rs7851726	0.624	rs12338859	MIMAT0019208	hsa-miR-3074-5p	3.93	9.89e-05	0.17	0.2	Urinary albumin-to-creatinine ratio;	chr9:94901338	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.646	rs2031698	MIMAT0019208	hsa-miR-3074-5p	-3.93	9.9e-05	-0.16	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94779050	chr9:95086063~95086083:-
STAD	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	3.93	9.93e-05	0.16	0.2	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	3.93	9.99e-05	0.16	0.2	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	3.93	9.99e-05	0.16	0.2	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	3.93	9.99e-05	0.16	0.2	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	3.93	9.99e-05	0.16	0.2	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	3.93	9.99e-05	0.16	0.2	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
STAD	cis	rs8064299	0.655	rs12797	MIMAT0017994	hsa-miR-3615	-3.93	9.99e-05	-0.17	-0.2	Monocyte count;	chr17:74770854	chr17:74748663~74748683:+
STAD	cis	rs12431410	0.542	rs10137320	MIMAT0022287	hsa-miR-5586-5p	-3.93	1e-04	-0.24	-0.2	Schizophrenia;	chr14:59673267	chr14:59646999~59647020:-
STAD	cis	rs6543140	0.601	rs78178597	MIMAT0019926	hsa-miR-4772-5p	3.93	1e-04	0.26	0.2	Blood protein levels;	chr2:102407136	chr2:102432300~102432321:+
STAD	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	3.93	0.000101	0.17	0.2	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	3.93	0.000101	0.17	0.2	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
STAD	cis	rs7851726	0.676	rs10821398	MIMAT0019208	hsa-miR-3074-5p	-3.93	0.000101	-0.16	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94815277	chr9:95086063~95086083:-
STAD	cis	rs10021731	0.83	rs4834421	MIMAT0003242	hsa-miR-577	3.93	0.000102	0.19	0.2	Optic disc area;	chr4:114572686	chr4:114656774~114656794:+
STAD	cis	rs9662615	0.618	rs1382599	MIMAT0003215	hsa-miR-552-3p	-3.93	0.000103	-0.21	-0.2	Response to lithium treatment in bipolar disorder;	chr1:34109010	chr1:34669614~34669634:-
STAD	cis	rs7851726	0.932	rs4744411	MIMAT0019208	hsa-miR-3074-5p	3.92	0.000103	0.16	0.2	Urinary albumin-to-creatinine ratio;	chr9:94926763	chr9:95086063~95086083:-
STAD	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
STAD	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	3.92	0.000103	0.16	0.2	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
STAD	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-3.92	0.000103	-0.24	-0.2	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
STAD	cis	rs7851726	0.69	rs4744386	MIMAT0019208	hsa-miR-3074-5p	-3.92	0.000103	-0.16	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94852359	chr9:95086063~95086083:-
STAD	cis	rs6724465	1	rs1052483	MIMAT0014996	hsa-miR-3131	3.92	0.000104	0.32	0.2	Height;	chr2:219069626	chr2:219058725~219058747:-
STAD	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-3.92	0.000106	-0.28	-0.2	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
STAD	cis	rs7851726	0.668	rs7862219	MIMAT0019208	hsa-miR-3074-5p	-3.92	0.000107	-0.16	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94889948	chr9:95086063~95086083:-
STAD	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-3.91	0.00011	-0.24	-0.2	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
STAD	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-3.91	0.00011	-0.24	-0.2	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	3.9	0.000112	0.23	0.2	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
STAD	cis	rs4846567	0.524	rs10746385	MIMAT0026476	hsa-miR-215-3p	-3.9	0.000114	-0.18	-0.2	Waist-hip ratio;	chr1:219533086	chr1:220117877~220117899:-
STAD	cis	rs7851726	0.966	rs10993398	MIMAT0019208	hsa-miR-3074-5p	3.9	0.000115	0.16	0.2	Urinary albumin-to-creatinine ratio;	chr9:94919793	chr9:95086063~95086083:-
STAD	cis	rs1014286	1	rs4851018	MIMAT0019926	hsa-miR-4772-5p	3.9	0.000116	0.2	0.19	Serum protein levels (sST2);	chr2:102530156	chr2:102432300~102432321:+
STAD	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-3.89	0.000116	-0.27	-0.19	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
STAD	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-3.89	0.000116	-0.16	-0.19	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
STAD	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-3.89	0.00012	-0.22	-0.19	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
STAD	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	3.88	0.000121	0.24	0.19	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
STAD	cis	rs3731896	0.898	rs7596956	MIMAT0014996	hsa-miR-3131	3.88	0.000123	0.23	0.19	Educational attainment;	chr2:219287637	chr2:219058725~219058747:-
STAD	cis	rs6724465	1	rs868945	MIMAT0014996	hsa-miR-3131	-3.88	0.000124	-0.31	-0.19	Height;	chr2:219059717	chr2:219058725~219058747:-
STAD	cis	rs6724465	1	rs17655003	MIMAT0014996	hsa-miR-3131	-3.88	0.000124	-0.31	-0.19	Height;	chr2:219065759	chr2:219058725~219058747:-
STAD	cis	rs8064299	0.655	rs16978176	MIMAT0017994	hsa-miR-3615	-3.88	0.000125	-0.17	-0.19	Monocyte count;	chr17:74765103	chr17:74748663~74748683:+
STAD	cis	rs1014286	1	rs4241211	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102526700	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.965	rs12712156	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102527561	chr2:102432300~102432321:+
STAD	cis	rs1014286	1	rs3849364	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102527783	chr2:102432300~102432321:+
STAD	cis	rs1014286	0.965	rs3849365	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102527932	chr2:102432300~102432321:+
STAD	cis	rs1014286	1	rs3849366	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102528441	chr2:102432300~102432321:+
STAD	cis	rs1014286	1	rs6739236	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102528485	chr2:102432300~102432321:+
STAD	cis	rs1014286	1	rs6712696	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102528542	chr2:102432300~102432321:+
STAD	cis	rs1014286	1	rs1005042	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000125	0.2	0.19	Serum protein levels (sST2);	chr2:102528900	chr2:102432300~102432321:+
STAD	cis	rs3788317	0.526	rs5992493	MIMAT0000455	hsa-miR-185-5p	-3.87	0.000125	-0.16	-0.19	Glaucoma (primary angle closure);	chr22:19894033	chr22:20033153~20033174:+
STAD	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	3.87	0.000127	0.28	0.19	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
STAD	cis	rs17854409	1	rs66634465	MIMAT0016888	hsa-miR-4326	-3.87	0.000129	-0.3	-0.19	Obesity-related traits;	chr20:62850954	chr20:63286818~63286837:+
STAD	cis	rs9662615	0.593	rs705218	MIMAT0003215	hsa-miR-552-3p	-3.87	0.00013	-0.21	-0.19	Response to lithium treatment in bipolar disorder;	chr1:34115035	chr1:34669614~34669634:-
STAD	cis	rs9662615	0.618	rs705216	MIMAT0003215	hsa-miR-552-3p	-3.87	0.00013	-0.21	-0.19	Response to lithium treatment in bipolar disorder;	chr1:34116390	chr1:34669614~34669634:-
STAD	cis	rs9662615	0.618	rs1065965	MIMAT0003215	hsa-miR-552-3p	-3.87	0.00013	-0.21	-0.19	Response to lithium treatment in bipolar disorder;	chr1:34117031	chr1:34669614~34669634:-
STAD	cis	rs7851726	0.966	rs7019822	MIMAT0019208	hsa-miR-3074-5p	-3.86	0.000131	-0.16	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94720609	chr9:95086063~95086083:-
STAD	cis	rs1014286	1	rs2015478	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000131	0.2	0.19	Serum protein levels (sST2);	chr2:102524988	chr2:102432300~102432321:+
STAD	cis	rs2066940	0.54	rs2045562	MIMAT0000510	hsa-miR-320a-3p	3.86	0.000133	0.17	0.19	Sitting height ratio;	chr8:21350726	chr8:22244975~22244996:-
STAD	cis	rs6724465	1	rs10208728	MIMAT0014996	hsa-miR-3131	-3.86	0.000133	-0.31	-0.19	Height;	chr2:219052581	chr2:219058725~219058747:-
STAD	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000134	0.16	0.19	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
STAD	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000134	0.16	0.19	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
STAD	cis	rs6681460	0.549	rs7537440	MIMAT0014979	hsa-miR-3117-3p	3.86	0.000135	0.25	0.19	Presence of antiphospholipid antibodies;	chr1:66566224	chr1:66628485~66628505:+
STAD	cis	rs6724465	0.636	rs72951772	MIMAT0014996	hsa-miR-3131	-3.86	0.000135	-0.3	-0.19	Height;	chr2:219126275	chr2:219058725~219058747:-
STAD	cis	rs6681460	0.549	rs963140	MIMAT0014979	hsa-miR-3117-3p	3.85	0.000136	0.25	0.19	Presence of antiphospholipid antibodies;	chr1:66571893	chr1:66628485~66628505:+
STAD	cis	rs6724465	0.852	rs7561119	MIMAT0014996	hsa-miR-3131	-3.85	0.000137	-0.31	-0.19	Height;	chr2:219121531	chr2:219058725~219058747:-
STAD	cis	rs2564921	0.73	rs2253675	MIMAT0000414	hsa-let-7g-5p	-3.85	0.000137	-0.2	-0.19	Height;	chr3:53085518	chr3:52268336~52268357:-
STAD	cis	rs6724465	1	rs13393738	MIMAT0014996	hsa-miR-3131	-3.85	0.000139	-0.32	-0.19	Height;	chr2:219049422	chr2:219058725~219058747:-
STAD	cis	rs990171	0.77	rs6543116	MIMAT0019926	hsa-miR-4772-5p	3.85	0.000139	0.22	0.19	Lymphocyte counts;	chr2:102311266	chr2:102432300~102432321:+
STAD	cis	rs2564921	0.73	rs2564922	MIMAT0000414	hsa-let-7g-5p	3.85	0.00014	0.2	0.19	Height;	chr3:53091453	chr3:52268336~52268357:-
STAD	cis	rs1466535	1	rs4759277	MIMAT0000082	hsa-miR-26a-5p	3.84	0.000141	0.12	0.19	Abdominal aortic aneurysm;	chr12:57139907	chr12:57824658~57824679:-
STAD	cis	rs1466535	1	rs4759277	MIMAT0000082_1	hsa-miR-26a-5p	3.84	0.000141	0.12	0.19	Abdominal aortic aneurysm;	chr12:57139907	chr3:37969413~37969434:+
STAD	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	3.84	0.000144	0.27	0.19	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
STAD	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-3.84	0.000144	-0.21	-0.19	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
STAD	cis	rs2564921	0.73	rs930122	MIMAT0000414	hsa-let-7g-5p	3.84	0.000145	0.2	0.19	Height;	chr3:53085313	chr3:52268336~52268357:-
STAD	cis	rs7894407	0.634	rs56060736	MIMAT0005951	hsa-miR-1307-3p	3.84	0.000146	0.16	0.19	White matter hyperintensity burden;	chr10:103310496	chr10:103394301~103394322:-
STAD	cis	rs7072216	0.666	rs11189592	MIMAT0026738	hsa-miR-1287-3p	3.83	0.000147	0.17	0.19	Metabolite levels;	chr10:98395885	chr10:98395232~98395253:-
STAD	cis	rs6681460	0.528	rs4655498	MIMAT0014979	hsa-miR-3117-3p	3.83	0.00015	0.25	0.19	Presence of antiphospholipid antibodies;	chr1:66573562	chr1:66628485~66628505:+
STAD	cis	rs10021731	0.756	rs1460783	MIMAT0003242	hsa-miR-577	-3.82	0.000153	-0.18	-0.19	Optic disc area;	chr4:114540109	chr4:114656774~114656794:+
STAD	cis	rs6724465	1	rs3731878	MIMAT0014996	hsa-miR-3131	-3.82	0.000154	-0.31	-0.19	Height;	chr2:219055843	chr2:219058725~219058747:-
STAD	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-3.82	0.000154	-0.26	-0.19	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
STAD	cis	rs6537837	1	rs6658855	MIMAT0000227	hsa-miR-197-3p	-3.82	0.000155	-0.14	-0.19	Major depressive disorder;	chr1:109580712	chr1:109598940~109598961:+
STAD	cis	rs9662615	0.618	rs2053218	MIMAT0003215	hsa-miR-552-3p	-3.82	0.000157	-0.2	-0.19	Response to lithium treatment in bipolar disorder;	chr1:34105779	chr1:34669614~34669634:-
STAD	cis	rs4851551	1	rs3917329	MIMAT0019927	hsa-miR-4772-3p	3.82	0.000159	0.35	0.19	Blood protein levels;	chr2:102179403	chr2:102432336~102432357:+
STAD	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.00016	-0.19	-0.19	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
STAD	cis	rs9847710	0.967	rs2581824	MIMAT0000414	hsa-let-7g-5p	-3.81	0.00016	-0.19	-0.19	Ulcerative colitis;	chr3:52988392	chr3:52268336~52268357:-
STAD	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	3.81	0.000162	0.21	0.19	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
STAD	cis	rs7851726	0.668	rs10821410	MIMAT0019208	hsa-miR-3074-5p	-3.81	0.000164	-0.16	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94880731	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.668	rs10761361	MIMAT0019208	hsa-miR-3074-5p	-3.81	0.000164	-0.16	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94882260	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.668	rs10081676	MIMAT0019208	hsa-miR-3074-5p	-3.81	0.000164	-0.16	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94892954	chr9:95086063~95086083:-
STAD	cis	rs10851411	0.657	rs62022313	MIMAT0026623	hsa-miR-627-3p	-3.81	0.000164	-0.33	-0.19	Glucose homeostasis traits;	chr15:42457278	chr15:42199593~42199612:-
STAD	cis	rs891088	0.922	rs34840745	MIMAT0019229	hsa-miR-3940-5p	3.81	0.000165	0.23	0.19	Height;Hip circumference adjusted for BMI;	chr19:7183786	chr19:6416470~6416489:-
STAD	cis	rs10993397	0.507	rs10993366	MIMAT0019208	hsa-miR-3074-5p	-3.8	0.000167	-0.16	-0.19	Polycystic ovary syndrome;	chr9:94844308	chr9:95086063~95086083:-
STAD	cis	rs1014286	1	rs1005043	MIMAT0019926	hsa-miR-4772-5p	-3.8	0.000169	-0.2	-0.19	Serum protein levels (sST2);	chr2:102528967	chr2:102432300~102432321:+
STAD	cis	rs1466535	1	rs4367982	MIMAT0000082	hsa-miR-26a-5p	3.79	0.000174	0.12	0.19	Abdominal aortic aneurysm;	chr12:57137849	chr12:57824658~57824679:-
STAD	cis	rs1466535	1	rs4367982	MIMAT0000082_1	hsa-miR-26a-5p	3.79	0.000174	0.12	0.19	Abdominal aortic aneurysm;	chr12:57137849	chr3:37969413~37969434:+
STAD	cis	rs6724465	1	rs56033548	MIMAT0014996	hsa-miR-3131	-3.79	0.000174	-0.31	-0.19	Height;	chr2:219071772	chr2:219058725~219058747:-
STAD	cis	rs7851726	0.69	rs7027708	MIMAT0019208	hsa-miR-3074-5p	-3.79	0.000175	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94748390	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.646	rs10821393	MIMAT0019208	hsa-miR-3074-5p	-3.79	0.000175	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94754478	chr9:95086063~95086083:-
STAD	cis	rs7851726	0.646	rs10739983	MIMAT0019208	hsa-miR-3074-5p	-3.79	0.000175	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94764002	chr9:95086063~95086083:-
STAD	cis	rs1014286	1	rs4851614	MIMAT0019926	hsa-miR-4772-5p	3.79	0.000175	0.2	0.19	Serum protein levels (sST2);	chr2:102523939	chr2:102432300~102432321:+
STAD	trans	rs4503939	0.536	rs6726882	MIMAT0004774	hsa-miR-501-3p	6.25	1.08e-09	0.31	0.3	Left  ventricle systolic dysfunction;	chr2:142485301	chrX:50009772~50009793:+
STAD	trans	rs10279573	0.898	rs7781214	MIMAT0018191	hsa-miR-3917	-6.02	4.04e-09	-0.43	-0.29	Cognitive performance;	chr7:110762829	chr1:25906384~25906403:-
STAD	trans	rs9513593	0.579	rs35309448	MIMAT0022500	hsa-miR-5706	6	4.68e-09	0.62	0.29	Psoriasis;	chr13:99224201	chr5:119154646~119154667:+
STAD	trans	rs9513593	0.579	rs12860697	MIMAT0022500	hsa-miR-5706	5.95	6.01e-09	0.56	0.29	Psoriasis;	chr13:99160711	chr5:119154646~119154667:+
STAD	trans	rs9513593	0.579	rs56864238	MIMAT0022500	hsa-miR-5706	5.85	1.07e-08	0.6	0.29	Psoriasis;	chr13:99172350	chr5:119154646~119154667:+
STAD	trans	rs6989175	0.57	rs2320889	MIMAT0004688	hsa-miR-374a-3p	-5.82	1.23e-08	-0.35	-0.28	QT interval;	chr8:25287297	chrX:74287295~74287316:-